<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28832794</article-id><article-id pub-id-type="pmc">5570396</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2017-0035</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>Coronary Perfusion Pressure during Antegrade Cardioplegia in On-Pump
CABG Patients</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Lopes</surname><given-names>Jackson Brand&#x000e3;o</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/></contrib><contrib contrib-type="author"><name><surname>dos Santos J&#x000fa;nior</surname><given-names>Carlos Cezar Monteiro</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><aff id="aff1">
<label>1</label> Faculdade de Medicina da Bahia da Universidade Federal da Bahia
(FMB-UFBA), Salvador, BA, Brazil.</aff></contrib-group><author-notes><corresp id="c1">Correspondence Address: Jackson Brand&#x000e3;o Lopes, Rua Reitor
Miguel Calmon, s/n - Vale do Canela - Salvador, BA, Brazil - Zip code:
40110-100. E-mail: <email>jackson.lopes@ufba.br</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>May-Jun</season><year>2017</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>May-Jun</season><year>2017</year></pub-date><volume>32</volume><issue>3</issue><fpage>171</fpage><lpage>176</lpage><history><date date-type="received"><day>01</day><month>3</month><year>2017</year></date><date date-type="accepted"><day>30</day><month>3</month><year>2017</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Objective</title><p>The aim of this study was to investigate whether aortic tension estimated by
palpation and cardioplegia infusion line pressure provide results equivalent
to those obtained with direct aortic intraluminal pressure measurement.</p></sec><sec><title>Methods</title><p>Sixty consecutive patients who underwent coronary artery bypass graft
surgeries with extracorporeal circulation were analyzed. Sanguineous
cardioplegic solution in a ratio of 4:1 was administered using a triple
lumen antegrade cannula. After crossclamping, cardioplegia was infused and
aortic root pressure was recorded by surgeon (A) considering the aortic
tension he felt in his fingertips. At the same time, another surgeon (B)
recorded his results for the same measurement. Concomitantly, the
anesthesiologist recorded intraluminal pressure in the aortic root and the
perfusionist recorded delta pressure in cardioplegia infusion line. None of
the participants involved in these measurements was allowed to be informed
about the values provided by the other examiners.</p></sec><sec><title>Results</title><p>The Bland-Altman test showed that a considerable variation between aortic
wall tension was found as measured by palpation and by intraluminal
pressure, with a bias of -9.911&#x000b1;18.75% (95% limits of agreement:
-46.7 to 26.9). No strong correlation was observed between intraluminal
pressure and cardioplegia line pressure (Spearman's r=0.61, 95% confidence
interval 0.5-0.7; <italic>P</italic>&#x0003c;0.0001).</p></sec><sec><title>Conclusion</title><p>These findings reinforce that cardioplegia infusion should be controlled by
measuring intraluminal pressure, and that palpation and cardioplegia line
pressure are inaccurate methods, the latter should always be used to
complement intraluminal measurement to ensure greater safety in handling the
cardioplegia circuit.</p></sec></abstract><kwd-group><kwd>Heart Arrest, Induced</kwd><kwd>Blood Pressure</kwd><kwd>Cardioplegic Solutions/*Administration &#x00026; Dosage</kwd><kwd>Coronary Artery Bypass</kwd><kwd>Coronary Artery Disease</kwd></kwd-group><funding-group><award-group><funding-source>Minist&#x000e9;rio da Ci&#x000ea;ncia, Tecnologia e
Inova&#x000e7;&#x000e3;o, Conselho Nacional de Desenvolvimento
Cient&#x000ed;fico e Tecnol&#x000f3;gico</funding-source><award-id>477558/2013-5</award-id></award-group><funding-statement>Financial Support: Minist&#x000e9;rio da Ci&#x000ea;ncia,
Tecnologia e Inova&#x000e7;&#x000e3;o, Conselho Nacional de Desenvolvimento
Cient&#x000ed;fico e Tecnol&#x000f3;gico 477558/2013-5.</funding-statement></funding-group></article-meta></front><body><table-wrap id="t5" orientation="portrait" position="anchor"><table frame="hsides" rules="groups" style="background-color:#e6e7e8"><colgroup span="1"><col width="50%" span="1"/><col width="50%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Abbreviations, acronyms &#x00026; symbols</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">CABG</td><td align="left" rowspan="1" colspan="1">= Coronary artery bypass graft</td></tr><tr><td align="left" rowspan="1" colspan="1">CPB</td><td align="left" rowspan="1" colspan="1">= Cardiopulmonary bypass</td></tr><tr><td align="left" rowspan="1" colspan="1">EACTS</td><td align="left" rowspan="1" colspan="1">= European Association for Cardio-Thoracic Surgery</td></tr><tr><td align="left" rowspan="1" colspan="1">EAPCI</td><td align="left" rowspan="1" colspan="1">= European Association for Percutaneous Cardiovascular
Interventions)</td></tr><tr><td align="left" rowspan="1" colspan="1">ESC</td><td align="left" rowspan="1" colspan="1">= European Society of Cardiology</td></tr><tr><td align="left" rowspan="1" colspan="1">LITA</td><td align="left" rowspan="1" colspan="1">= Left internal thoracic artery</td></tr><tr><td align="left" rowspan="1" colspan="1">LOA</td><td align="left" rowspan="1" colspan="1">= Limits of agreement</td></tr><tr><td align="left" rowspan="1" colspan="1">SUS</td><td align="left" rowspan="1" colspan="1">= Sistema &#x000da;nico de Sa&#x000fa;de (Brazilian public
health system)</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Ischemic heart disease is a major cause of death in Brazil. In 2010, there were
99,955 deaths from ischemic heart disease in the country, with a mortality rate of
52.4/100,000 population<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>.</p><p>In 2015, 20,198 coronary artery bypass graft (CABG) surgeries were performed with
cardiopulmonary bypass (CPB) in Brazil<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>. Over the past few years, the profile of patients undergoing
this surgery has changed, due to advances in percutaneous revascularization and
improved clinical treatment<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>.
Since the 1990s, studies have shown that today these patients are older, sicker, and
have a higher risk than in the past<sup>[<xref rid="r4" ref-type="bibr">4</xref>,<xref rid="r5" ref-type="bibr">5</xref>]</sup>, which urges
healthcare professionals to optimize care to reduce mortality rates<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup>.</p><p>Myocardial protection is a critical point in on-pump CABG surgeries, and infusion
pressure should be carefully monitored in order to avoid possible endothelial
damages and reperfusion injuries<sup>[<xref rid="r6" ref-type="bibr">6</xref>,<xref rid="r7" ref-type="bibr">7</xref>]</sup>.</p><p>The estimation of infusion pressure during antegrade cardioplegia is based on the
measurement of pressure in the initial portion of the aorta. The gold standard to
determine aortic pressure is direct intraluminal measurement using a pressure
monitoring line attached to the cardioplegia cannula. Currently, the Brazilian
Unified Health System does not consider cannulas in compatible material list for
CABG surgeries, thus making it difficult to monitor pressure during infusion of
myocardial protection solution. In Brazil, the most used method to monitor aortic
root pressure in surgeries is palpation with surgeon's fingertips, a method that may
be considered subjective and vary according to surgeon's state of perception,
experience, and sensitivity.</p><p>Hence, this study aimed to investigate whether aortic palpation and measurement of
delta pressure in cardioplegia infusion line are equivalent to direct intraluminal
measurement.</p></sec><sec sec-type="methods"><title>METHODS</title><p>This prospective study shows the results of a quantitative exploratory-descriptive
research with 60 consecutive patients who underwent elective on-pump CABG surgery
from January 2014 to October 2014. The study was approved by the Human Research
Ethics Committee of Centro Universit&#x000e1;rio do Leste de Minas Gerais/ UNILESTE -
Uni&#x000e3;o Brasiliense de Educa&#x000e7;&#x000e3;o e Cultura under no.
14142013.8.0000.5095.</p><sec><title>Eligibility Criteria</title><p>Patients of both sexes were included in this study. Selection criteria for CABG
followed the norms established in the European Society of Cardiology (ESC),
European Association for Cardio-Thoracic Surgery (EACTS) and European
Association for Percutaneous Cardiovascular Interventions (EAPCI) Guidelines of
Myocardial Revascularization 2010<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>. Patients were referred from the Department of
Cardiovascular Surgery of Hospital M&#x000e1;rcio Cunha / Funda&#x000e7;&#x000e3;o
S&#x000e3;o Francisco Xavier, Ipatinga, Brazil, for routine surgeries. Patients
indicated for on-pump CABG surgery who required other concomitant surgical
procedures were excluded.</p></sec><sec><title>Surgical Procedure</title><p>Myocardial protection was accomplished with cold (4&#x000b0;C) hyperkalemic blood (4:1)
cardioplegia. The cardioplegic solution was administered using a triple lumen
antegrade cardioplegic cannula (ATC011MV model, Edwards Lifesciences Inc., USA).
One lumen was used for infusion, one for aspiration, and one for measurement of
intraluminal pressure in the aortic root. This was measured by connecting the
respective lumen to a Truwave PX 260 transducer (Edwards Lifesciences Inc., USA)
that converts mechanical signals into electrical signals, and mean blood
pressure was displayed in a DX 2020 multiparameter monitor (Dixtal, Brazil).</p><p>After heparinization and implementation of CPB using a Brizio<sup>&#x000ae;</sup>
membrane oxygenator (Nipro Medical Ltda., Brazil), the patient was kept at a
systemic temperature of 34&#x000b0;C and the cardioplegia delivery system
(Unique<sup>&#x000ae;</sup>, Nipro Medical Ltda., Brazil) was filled with
blood and hyperkalemic crystalloid solution to remove the air from tubes and
connectors. After occlusion of the ascending aorta, the left ventricle was
initially suctioned by the cardioplegia cannula and the ascending aorta was
perfused with the cardioplegia solution, which was infused at a flow rate of 300
ml/min until reaching a total volume of 10 ml/kg. Cardioplegia flow was adjusted
according to aortic wall tension as estimated by the principal surgeon (A),
using his fingertips. Aortic root pressure was recorded by surgeon (A)
considering the aortic tension he considered adequate for coronary perfusion. At
the same time, another surgeon (B), recorded his results for the same
measurement. Concomitantly, the anesthesiologist recorded intraluminal pressure
in the aortic root and the perfusionist recorded delta pressure in cardioplegia
infusion line. None of the participants involved in these measurements was
allowed to be informed about the values provided by the other examiners. This
procedure was performed during every infusion of cardioplegia solution.</p></sec><sec><title>Statistical Analysis</title><p>Data were analyzed using the Graphpad Prism 5 software, version 5D. Quantitative
variables having a Gaussian distribution were described as mean &#x000b1;
standard deviation and those not having a Gaussian distribution were described
as median (25<sup>th</sup> percentile-75<sup>th</sup> percentile). In turn,
qualitative variables were described as absolute and relative frequencies. Data
normality was tested using the Kolmogorov-Smirnov, Shapiro-Wilk, and D'Agostino
tests. The degree of agreement between surgeons' measurements of aortic tension
and between intraluminal pressures and measurements of aortic tension were
assessed by the Bland-Altman test. The Spearman's correlation test was used to
evaluate the association between intraluminal pressure and cardioplegia line
pressure. Differences were considered significant when probability level was
lower or equal to 0.05.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><sec><title>Overall Results</title><p>Demographic and comorbidity data are shown in <xref ref-type="table" rid="t1">Table 1</xref>. Intraoperative findings (<xref ref-type="table" rid="t2">Table 2</xref>) showed a mean number of grafts corresponding to the number
of obstructed vessels, and anterior intraventricular artery was revascularized
in all cases with left internal thoracic artery (LITA). In 10% of cases, the
LITA was used to revascularize a second vessel. Saphenous vein graft was always
the second more used graft rather than radial graft. Thirty-day mortality rate
was 1.7%, and the incidence of atrial fibrillation and renal dysfunction was
8.3% and 5%, respectively. None of these cases evolved to need for renal
replacement therapy. No cases of postoperative infection or stroke were observed
(<xref ref-type="table" rid="t3">Table 3</xref>).</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Demography and comorbidity data.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="50%" span="1"/><col width="50%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Variable</th><th align="center" rowspan="1" colspan="1">n = 60</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="center" rowspan="1" colspan="1">64&#x000b1;8<xref ref-type="table-fn" rid="TFN2">#</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Male, n (%)</td><td align="center" rowspan="1" colspan="1">51 (85%)</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI</td><td align="center" rowspan="1" colspan="1">27&#x000b1;4.3<xref ref-type="table-fn" rid="TFN2">#</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Obese patients</td><td align="center" rowspan="1" colspan="1">16 (26.6%)</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI &#x0003c; 25 kg/m<sup>2</sup></td><td align="center" rowspan="1" colspan="1">19 (31.6%)</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI from 25 to 29.9 kg/m<sup>2</sup></td><td align="center" rowspan="1" colspan="1">25 (41.6%)</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI from 30 to 34.9 kg/m<sup>2</sup></td><td align="center" rowspan="1" colspan="1">13 (21.6%)</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI &#x0003e; 35 kg/m<sup>2</sup></td><td align="center" rowspan="1" colspan="1">3 (5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypertension, n (%)</td><td align="center" rowspan="1" colspan="1">51 (85%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Smoking, n (%)</td><td align="center" rowspan="1" colspan="1">29 (48.3%)</td></tr><tr><td align="left" rowspan="1" colspan="1">COPD</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Diabetes, n (%)</td><td align="center" rowspan="1" colspan="1">17 (28.3%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Pacemaker, n (%)</td><td align="center" rowspan="1" colspan="1">1 (1.7%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Previous AMI, n (%)</td><td align="center" rowspan="1" colspan="1">13 (21.6%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Cerebrovascular disease, n (%)</td><td align="center" rowspan="1" colspan="1">8 (13.3%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Stroke, n (%)</td><td align="center" rowspan="1" colspan="1">1 (1.7%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Peripheral vascular disease, n (%)</td><td align="center" rowspan="1" colspan="1">2 (3.3%)</td></tr><tr><td align="left" rowspan="1" colspan="1">CRF requiring dialysis</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Atrial fibrillation</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">ASA</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">P2Y12 inhibitor</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Hemoglobin</td><td align="center" rowspan="1" colspan="1">13.5 &#x000b1; 1.7<xref ref-type="table-fn" rid="TFN2">#</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Creatinine (mg/dL)</td><td align="center" rowspan="1" colspan="1">0.9 (0.8&#x02013;1.1)<xref ref-type="table-fn" rid="TFN8">$</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">LVEF</td><td align="center" rowspan="1" colspan="1">0.59&#x000b1;0.09<xref ref-type="table-fn" rid="TFN2">#</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02265; 0.5</td><td align="center" rowspan="1" colspan="1">89.8%</td></tr><tr><td align="left" rowspan="1" colspan="1">0.4 to 0.49</td><td align="center" rowspan="1" colspan="1">8.3%</td></tr><tr><td align="left" rowspan="1" colspan="1">0.3 to 0.39</td><td align="center" rowspan="1" colspan="1">1.7%</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02264; 0.3</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Pulmonary hypertension</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Moderate, n (%)</td><td align="center" rowspan="1" colspan="1">8 (13.3%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Severe</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Obstructed vessels</td><td align="center" rowspan="1" colspan="1">3.0&#x000b1;1.2<xref ref-type="table-fn" rid="TFN2">#</xref></td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>BMI=body mass index; COPD=chronic obstructive pulmonary disease;
AMI=acute myocardial infarction; CRF=chronic renal failure;
ASA=acetylsalicylic acid; LV=left ventricle</p></fn><fn id="TFN2"><label>#</label><p>mean &#x000b1; standard deviation; </p></fn><fn id="TFN3"><label>$</label><p>median &#x000b1; interquartile range (p25-p75)</p></fn></table-wrap-foot></table-wrap><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Intraoperative variables.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="50%" span="1"/><col width="50%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Variable</th><th align="center" rowspan="1" colspan="1">n = 60</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Grafts</td><td align="center" rowspan="1" colspan="1">3.1 &#x000b1; 0.9<xref ref-type="table-fn" rid="TFN5">#</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Arterial grafts</td><td align="center" rowspan="1" colspan="1">1 (1&#x02013;1)<xref ref-type="table-fn" rid="TFN8">$</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Venous grafts</td><td align="center" rowspan="1" colspan="1">2 (1.5&#x02013;3)<xref ref-type="table-fn" rid="TFN8">$</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">LITA -&#x0003e; AIVA, n (%)</td><td align="center" rowspan="1" colspan="1">60 (100%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Sequential LITA, n (%)</td><td align="center" rowspan="1" colspan="1">6 (10%)</td></tr><tr><td align="left" rowspan="1" colspan="1">RITA</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Radial graft</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Time in the operating room (h)</td><td align="center" rowspan="1" colspan="1">3.9&#x000b1;0.9<xref ref-type="table-fn" rid="TFN5">#</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Bypass time (min)</td><td align="center" rowspan="1" colspan="1">92.7&#x000b1;25.7<xref ref-type="table-fn" rid="TFN5">#</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Clamping time (min)</td><td align="center" rowspan="1" colspan="1">83&#x000b1;26.4<xref ref-type="table-fn" rid="TFN5">#</xref></td></tr></tbody></table><table-wrap-foot><fn id="TFN4"><p>LITA=left internal thoracic artery; AIVA=anterior interventricular
artery; RITA=right internal thoracic artery</p></fn><fn id="TFN5"><label>#</label><p>mean &#x000b1; standard deviation; </p></fn><fn id="TFN6"><label>$</label><p>median &#x000b1; interquartile range (p25-p75)</p></fn></table-wrap-foot></table-wrap><table-wrap id="t3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Postoperative outcomes.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="50%" span="1"/><col width="50%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Variable</th><th align="center" rowspan="1" colspan="1">n = 60</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">ICU length of stay until extubation (h)</td><td align="center" rowspan="1" colspan="1">4 (3&#x02013;5)<xref ref-type="table-fn" rid="TFN8">$</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Postoperative length of stay (days)</td><td align="center" rowspan="1" colspan="1">5 (4&#x02013;6)<xref ref-type="table-fn" rid="TFN8">$</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Volume of liquid drained after 12 h (9)</td><td align="center" rowspan="1" colspan="1">300 (228&#x02013;400)<xref ref-type="table-fn" rid="TFN8">$</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Dobutamine (mcg/kg)</td><td align="center" rowspan="1" colspan="1">___ <xref ref-type="table-fn" rid="TFN8">$</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Noradrenaline (mcg/kg)</td><td align="center" rowspan="1" colspan="1">0 (0&#x02013;26)<xref ref-type="table-fn" rid="TFN8">$</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Creatinine peak (mg/dL)</td><td align="center" rowspan="1" colspan="1">1.1 (0.8&#x02013;1.4)<xref ref-type="table-fn" rid="TFN8">$</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">CK-MB peak (U/l)</td><td align="center" rowspan="1" colspan="1">49 (29&#x02013;63) <xref ref-type="table-fn" rid="TFN8">$</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">CPK peak (U/l)</td><td align="center" rowspan="1" colspan="1">664 (449&#x02013;926)<xref ref-type="table-fn" rid="TFN8">$</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Lactate peak (mg/dl)</td><td align="center" rowspan="1" colspan="1">57 (39&#x02013;72)<xref ref-type="table-fn" rid="TFN8">$</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Post-CPB TTPa (sec)</td><td align="center" rowspan="1" colspan="1">35 (31&#x02013;39)<xref ref-type="table-fn" rid="TFN8">$</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Post-CPB INR</td><td align="center" rowspan="1" colspan="1">1.6 (1.5&#x02013;1.7)<xref ref-type="table-fn" rid="TFN8">$</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Post-CPB platelets (10x3)</td><td align="center" rowspan="1" colspan="1">162 (128&#x02013;195)<xref ref-type="table-fn" rid="TFN8">$</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Readmission, n (%)</td><td align="center" rowspan="1" colspan="1">1 (1.7%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Respiratory infection</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Wound infection</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Superficial</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Urinary infection</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Stroke</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Atrial fibrillation, n (%)</td><td align="center" rowspan="1" colspan="1">5 (8.3%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Reoperation</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Renal dysfunction, n (%)</td><td align="center" rowspan="1" colspan="1">3 (5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Death, n (%)</td><td align="center" rowspan="1" colspan="1">1 (1.7%)</td></tr></tbody></table><table-wrap-foot><fn id="TFN7"><p>ICU=intensive care unit; CK-MB=creatine kinase-myocardial band;
CPK=creatine phosphokinase; CPB= cardiopulmonary bypass </p></fn><fn id="TFN8"><label>$</label><p>median &#x000b1; interquartile range (p25-p75)</p></fn></table-wrap-foot></table-wrap><p><xref ref-type="table" rid="t4">Table 4</xref> shows data on arterial (aortic)
tension as measured by A and B surgeons, intraluminal pressure, and cardioplegia
line pressure following the sequence of repetitions of cardioplegia
infusions.</p><table-wrap id="t4" orientation="portrait" position="float"><label>Table 4</label><caption><p>Pressures/tensions during cardioplegia infusions.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/></colgroup><thead><tr><th align="center" rowspan="2" colspan="1">&#x000a0;</th><th align="center" colspan="3" rowspan="1">Time point</th></tr><tr><th align="center" rowspan="1" colspan="1">First cardioplegia Median (p25&#x02013;p75)</th><th align="center" rowspan="1" colspan="1">Second cardioplegia Median (p25&#x02013;p75)</th><th align="center" rowspan="1" colspan="1">Third cardioplegia Median (p25&#x02013;p75)</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">Surgeon A</td><td align="center" rowspan="1" colspan="1">55 (45&#x02013;60)</td><td align="center" rowspan="1" colspan="1">60 (50&#x02013;65)</td><td align="center" rowspan="1" colspan="1">60 (50&#x02013;65)</td></tr><tr><td align="center" rowspan="1" colspan="1">Surgeon B</td><td align="center" rowspan="1" colspan="1">55 (45&#x02013;60)</td><td align="center" rowspan="1" colspan="1">60 (50&#x02013;65)</td><td align="center" rowspan="1" colspan="1">55 (45&#x02013;66)</td></tr><tr><td align="center" rowspan="1" colspan="1">Intraluminal pressure (mmHg)</td><td align="center" rowspan="1" colspan="1">62 (56&#x02013;68)</td><td align="center" rowspan="1" colspan="1">61 (56&#x02013;66)</td><td align="center" rowspan="1" colspan="1">60 (54&#x02013;64)</td></tr><tr><td align="center" rowspan="1" colspan="1">Cardioplegia line pressure (mmHg)</td><td align="center" rowspan="1" colspan="1">140 (130&#x02013;150)</td><td align="center" rowspan="1" colspan="1">140 (126&#x02013;140)</td><td align="center" rowspan="1" colspan="1">140 (129&#x02013;150)</td></tr></tbody></table></table-wrap></sec><sec><title>Aortic wall tension - Agreement between surgeons A and B</title><p>Aortic wall tension during the first cardioplegia infusion had a bias of
-3.4&#x000b1;21.11% (95% limits of agreement [LOA]: -44.79 to 37.98).
Inter-surgeon differences (A-B) had skewness of -0.67 and kurtosis of 1.1, with
normal distribution according to the Kolmogorov-Smirnov test. During the second
cardioplegia infusion, bias was -0.9&#x000b1;18.58% (95% LOA: -37.35 to 35.46).
Intersurgeon differences (A-B) had skewness of 0.07 and kurtosis of 0.11, with
normal distribution according to the Kolmogorov-Smirnov test. During the third
cardioplegia infusion, bias -0.9424&#x000b1;18.58% (95%LOA: -37.35 to 35.46).
Intersurgeon differences (A-B) had skewness of 0.21 and kurtosis of 0.05, with
normal distribution according to the Kolmogorov-Smirnov test (<xref ref-type="fig" rid="f1">Figure 1</xref>).</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Bland-Altman plot comparing differences between the arterial tension
measurements made by surgeons A and B.</p></caption><graphic xlink:href="rbccv-32-03-0171-g01"/></fig>
</p></sec><sec><title>Agreement between intraluminal pressure and mean aortic wall tension as
measured by surgeons A and B</title><p>Mean values for each measurement of aortic wall tension (T) were calculated as
follows: (T surgeon A + T surgeon B)/2. The agreement between these values and
intraluminal pressure had a bias of -9.911&#x000b1;18.75% (95% LOA: -46.7 to
26.9). Differences between intraluminal pressure and mean aortic wall tension as
measured by surgeons A and B had skewness of -0.3 and kurtosis of 1.0, with
normal distribution according to the Kolmogorov-Smirnov test (<xref ref-type="fig" rid="f2">Figure 2</xref>). The Spearman's rank correlation
test found a weak correlation between the variables (r=0.25) (95% confidence
interval [95%CI] 0.09-0.40); <italic>P</italic>=0.0021 (<xref ref-type="fig" rid="f3">Figure 3</xref>).</p><p>
<fig id="f2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Bland-Altman plot comparing intraluminal pressure and mean aortic
wall tension as measured by surgeons A and B.</p></caption><graphic xlink:href="rbccv-32-03-0171-g02"/></fig>
</p><p>
<fig id="f3" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>Spearman's rank correlation coefficient between intraluminal pressure
and mean aortic wall tension as measured by surgeons A and B.</p></caption><graphic xlink:href="rbccv-32-03-0171-g03"/></fig>
</p></sec><sec><title>Correlation between intraluminal pressure and cardioplegia line
pressure</title><p>A moderate correlation was observed between intraluminal pressure and
cardioplegia line pressure, with a Spearman's r=0.61 (95%IC; 0.5-0.7);
<italic>P</italic>&#x0003c;0.0001 (<xref ref-type="fig" rid="f4">Figure
4</xref>).</p><p>
<fig id="f4" orientation="portrait" position="float"><label>Fig. 4</label><caption><p>Spearman's rank correlation coefficient between intraluminal pressure
and cardioplegia line pressure. Spearman's r=0.61 (95%CI 0.5-0.7);
P&#x0003c;0.0001. R2=0.49; P&#x0003c;0.0001.</p></caption><graphic xlink:href="rbccv-32-03-0171-g04"/></fig>
</p></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>Many authors have discussed the effects of the different types of
cardioplegia<sup>[<xref rid="r9" ref-type="bibr">9</xref>-<xref rid="r11" ref-type="bibr">11</xref>]</sup>. Antegrade and/or retrograde
delivery of cardioplegia has also been a matter of constant debate<sup>[<xref rid="r12" ref-type="bibr">12</xref>-<xref rid="r14" ref-type="bibr">14</xref>]</sup>. During retrograde delivery of solutions, there is usual
concern with coronary sinus pressure because of its fragility and cases of rupture.
With regard to antegrade administration, a recent survey showed that 95% of centers
in the northeast United States usually measure cardioplegia line pressure<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup>; however, this pressure is
influenced by many interfering variables, such as circuit resistance due to its
caliber and length, flow velocity, viscosity and temperature of the infused
solution, and system afterload.</p><p>A study compared the direct measurement of intraluminal pressure with pressure
estimation by aortic palpation and variation of cardioplegia line
pressure<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup>. As a result,
the study showed that there was little correlation between measurements obtained
directly and indirectly and that direct intravascular measurement is the most
reliable method to determine aortic pressure during cardioplegic infusion and to
ensure process effectiveness and safety. In agreement with Kato et al.<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup>, our study found only a moderate
correlation between cardioplegia line pressure and direct intraluminal measurement
in the aortic root; therefore, cardioplegia line pressure should be used to
investigate possible folds or obstructions during infusion, thus preventing
accidents, such as circuit rupture resulting in risk of transmission of diseases due
to inadvertent contact with blood, and avoiding high pressures usually associated
with hemolysis.</p><p>The limitations of the study by Kato et al.<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup> lay in the fact that it assessed cardioplegia delivery in
only 10 patients and that the methods of cardioplegia varied among these patients.
Some patients were given an antegrade infusion and others were given a retrograde
infusion, methods that show a significant variation in infusion pressure. As in our
study, the authors compared the measurement of aortic arterial tension by palpation
and by intraluminal pressure. In line with their findings, our study did not find a
significant correlation between these two measuring techniques and observed a
possibly clinically acceptable bias but with very wide limits of agreement, which
would lead to important inaccuracies when pressure is measured by palpation.</p><p>In addition to the divergence between measurements obtained by aortic palpation and
by intraluminal examination, it is worth noting that the first method may be
influenced by subjective confounding factors such as surgeon's experience. Our study
found a small bias in interobserver comparison, but the presence of high LOA shows
considerable variations between measurements.</p><p>The present study has some limitations, such as the lack of evaluation of the
influence of aortic diameter on the result of the measurement of aortic tension by
palpation and the fact that this study was not designed to assess postoperative
outcomes related with the method used to control cardioplegia infusion pressure.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>The present findings reinforce that cardioplegia infusion should be controlled by
measuring intraluminal pressure and that palpation and cardioplegia line pressure
are inaccurate methods, and the latter should always be used to complement
intraluminal measurement to ensure greater safety in handling of the cardioplegia
circuit. These findings also support the inclusion of dual or triple lumen cannulas
for antegrade cardioplegia delivery into the Brazilian public health system (SUS)
materials list applied for cardiac surgeries in Brazil performed in the Public
Health System, which certainly account for the majority of cases operated in this
country.</p><table-wrap id="t6" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="50%" span="1"/><col width="50%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Authors' roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">JBL</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or the acquisition, analysis, or interpretation of data
for the work; drafting the work or revising it critically for
important intellectual content; agreement to be accountable for all
aspects of the work in ensuring that questions related to the
accuracy or integrity of any part of the work are appropriately
investigated and resolved; final approval of the version to be
published</td></tr><tr><td align="left" rowspan="1" colspan="1">CCMSJ</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or the acquisition, analysis, or interpretation of data
for the work; drafting the work or revising it critically for
important intellectual content; agreement to be accountable for all
aspects of the work in ensuring that questions related to the
accuracy or integrity of any part of the work are appropriately
investigated and resolved; final approval of the version to be
published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn><fn fn-type="other"><p>This study was carried out at Faculdade de Medicina da Bahia da Universidade
Federal da Bahia (FMB-UFBA), Salvador, BA, Brazil.</p></fn><fn fn-type="financial-disclosure"><p>Financial Support: Minist&#x000e9;rio da Ci&#x000ea;ncia, Tecnologia e
Inova&#x000e7;&#x000e3;o, Conselho Nacional de Desenvolvimento Cient&#x000ed;fico e
Tecnol&#x000f3;gico 477558/2013-5.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="webpage"><source>&#x000d3;bitos por doen&#x000e7;a isqu&#x000ea;mica do
cora&#x000e7;&#x000e3;o: DATASUS</source><year>2013</year><date-in-citation content-type="access-date">2017</date-in-citation><comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://tabnet.datasus.gov.br/cgi/tabcgi.exe?idb2011/c08.def">http://tabnet.datasus.gov.br/cgi/tabcgi.exe?idb2011/c08.def</ext-link></comment></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="webpage"><source>Procedimentos hospitalares do SUS - por local de
interna&#x000e7;&#x000e3;o - Brasil: DATASUS</source><year>2015</year><date-in-citation content-type="access-date">2017</date-in-citation><comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://tabnet.datasus.gov.br/cgi/tabcgi.exe?sih/cnv/qiuf.def">http://tabnet.datasus.gov.br/cgi/tabcgi.exe?sih/cnv/qiuf.def</ext-link></comment></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>ElBardissi</surname><given-names>AW</given-names></name><name><surname>Aranki</surname><given-names>SF</given-names></name><name><surname>Sheng</surname><given-names>S</given-names></name><name><surname>O'Brien</surname><given-names>SM</given-names></name><name><surname>Greenberg</surname><given-names>CC</given-names></name><name><surname>Gammie</surname><given-names>JS</given-names></name></person-group><article-title>Trends in isolated coronary artery bypass grafting: an analysis
of the Society of Thoracic Surgeons adult cardiac surgery
database</article-title><source>J Thorac Cardiovasc Surg</source><year>2012</year><volume>143</volume><issue>2</issue><fpage>273</fpage><lpage>281</lpage><pub-id pub-id-type="pmid">22248680</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferguson</surname><given-names>TB</given-names><suffix>Jr</suffix></name><name><surname>Hammill</surname><given-names>BG</given-names></name><name><surname>Peterson</surname><given-names>ED</given-names></name><name><surname>DeLong</surname><given-names>ER</given-names></name><name><surname>Grover</surname><given-names>FL</given-names></name><collab>STS National Database Committee</collab></person-group><article-title>A decade of change: risk profiles and outcomes for isolated
coronary artery bypass grafting procedures, 1990-1999: a report from the STS
National Database Committee and the Duke Clinical Research Institute.
Society of Thoracic Surgeons</article-title><source>Ann Thorac Surg</source><year>2002</year><volume>73</volume><issue>2</issue><fpage>480</fpage><lpage>489</lpage><pub-id pub-id-type="pmid">11845863</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cornwell</surname><given-names>LD</given-names></name><name><surname>Omer</surname><given-names>S</given-names></name><name><surname>Rosengart</surname><given-names>T</given-names></name><name><surname>Holman</surname><given-names>WL</given-names></name><name><surname>Bakaeen</surname><given-names>FG</given-names></name></person-group><article-title>Changes over time in risk profiles of patients who undergo
coronary artery bypass graft surgery: the Veterans Affairs Surgical Quality
Improvement Program (VASQIP)</article-title><source>JAMA Surg</source><year>2015</year><volume>150</volume><issue>4</issue><fpage>308</fpage><lpage>315</lpage><pub-id pub-id-type="pmid">25671647</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katayama</surname><given-names>O</given-names></name><name><surname>Amrani</surname><given-names>M</given-names></name><name><surname>Ledingham</surname><given-names>S</given-names></name><name><surname>Jayakumar</surname><given-names>J</given-names></name><name><surname>Smolenski</surname><given-names>RT</given-names></name><name><surname>Severs</surname><given-names>N</given-names></name><etal/></person-group><article-title>Effect of cardioplegia infusion pressure on coronary artery
endothelium and cardiac mechanical function</article-title><source>Eur J Cardiothorac Surg</source><year>1997</year><volume>11</volume><issue>4</issue><fpage>751</fpage><lpage>762</lpage><pub-id pub-id-type="pmid">9151049</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irtun</surname><given-names>O</given-names></name><name><surname>Sorlie</surname><given-names>D</given-names></name></person-group><article-title>High cardioplegic perfusion pressure entails reduced myocardial
recovery</article-title><source>Eur J Cardiothorac Surg</source><year>1997</year><volume>11</volume><issue>2</issue><fpage>358</fpage><lpage>362</lpage><pub-id pub-id-type="pmid">9080168</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Task Force on Myocardial Revascularization of the European Society
of Cardiology (ESC)</collab><collab>European Association for Cardio-Thoracic Surgery (EACTS)</collab><collab>European Association for Percutaneous Cardiovascular Interventions
(EAPCI)</collab><name><surname>Wijns</surname><given-names>W</given-names></name><name><surname>Kolh</surname><given-names>P</given-names></name><name><surname>Danchin</surname><given-names>N</given-names></name><name><surname>Di Mario</surname><given-names>C</given-names></name><name><surname>Falk</surname><given-names>V</given-names></name><name><surname>Folliguet</surname><given-names>T</given-names></name><etal/></person-group><article-title>Guidelines on myocardial revascularization</article-title><source>Eur Heart J</source><year>2010</year><volume>31</volume><issue>20</issue><fpage>2501</fpage><lpage>2555</lpage><pub-id pub-id-type="pmid">20802248</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>P</given-names></name><name><surname>Jadhav</surname><given-names>RB</given-names></name><name><surname>Mohapatra</surname><given-names>CK</given-names></name><name><surname>Khandekar</surname><given-names>J</given-names></name><name><surname>Raut</surname><given-names>C</given-names></name><name><surname>Ammannaya</surname><given-names>GK</given-names></name><etal/></person-group><article-title>Comparison of del Nido cardioplegia and St. Thomas Hospital
solution: two types of cardioplegia in adult cardiac surgery</article-title><source>Kardiochir Torakochirurgia Pol</source><year>2016</year><volume>13</volume><issue>4</issue><fpage>295</fpage><lpage>299</lpage><pub-id pub-id-type="pmid">28096823</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Preusse</surname><given-names>CJ</given-names></name></person-group><article-title>Custodiol cardioplegia: a single-dose hyperpolarizing
solution</article-title><source>J Extra Corpor Technol</source><year>2016</year><volume>48</volume><issue>2</issue><fpage>P15</fpage><lpage>P20</lpage><pub-id pub-id-type="pmid">27578901</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>MA</given-names></name><name><surname>Brandi</surname><given-names>AC</given-names></name><name><surname>Santos</surname><given-names>CA</given-names></name><name><surname>Botelho</surname><given-names>PH</given-names></name><name><surname>Cortez</surname><given-names>JL</given-names></name><name><surname>Godoy</surname><given-names>MF</given-names></name><etal/></person-group><article-title>Comparison of fractal dimension and Shannon entropy in myocytes
from rats treated with histidine-tryptophan-glutamate and
histidine-tryptophan cetoglutarate</article-title><source>Rev Bras Cir Cardiovasc</source><year>2014</year><volume>29</volume><issue>2</issue><fpage>156</fpage><lpage>162</lpage><pub-id pub-id-type="pmid">25140464</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Najjar</surname><given-names>M</given-names></name><name><surname>George</surname><given-names>I</given-names></name><name><surname>Akashi</surname><given-names>H</given-names></name><name><surname>Nishimura</surname><given-names>T</given-names></name><name><surname>Yerebakan</surname><given-names>H</given-names></name><name><surname>Mongero</surname><given-names>L</given-names></name><etal/></person-group><article-title>Feasibility and safety of continuous retrograde administration of
Del Nido cardioplegia: a case series</article-title><source>J Cardiothorac Surg</source><year>2015</year><volume>10</volume><fpage>176</fpage><lpage>176</lpage><pub-id pub-id-type="pmid">26612068</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cobert</surname><given-names>ML</given-names></name><name><surname>Merritt</surname><given-names>ME</given-names></name><name><surname>West</surname><given-names>LM</given-names></name><name><surname>Ayers</surname><given-names>C</given-names></name><name><surname>Jessen</surname><given-names>ME</given-names></name><name><surname>Peltz</surname><given-names>M</given-names></name></person-group><article-title>Metabolic characteristics of human hearts preserved for 12 hours
by static storage, antegrade perfusion, or retrograde coronary sinus
perfusion</article-title><source>J Thorac Cardiovasc Surg</source><year>2014</year><volume>148</volume><issue>5</issue><fpage>2310</fpage><lpage>2315</lpage><pub-id pub-id-type="pmid">24642559</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mej&#x000ed;a</surname><given-names>OA</given-names></name><name><surname>Lisboa</surname><given-names>LA</given-names></name><name><surname>Tiveron</surname><given-names>MG</given-names></name><name><surname>Santiago</surname><given-names>JA</given-names></name><name><surname>Tineli</surname><given-names>RA</given-names></name><name><surname>Dallan</surname><given-names>LA</given-names></name><etal/></person-group><article-title>Coronary artery bypass grafting in acute myocardial infarction:
analysis of predictors of in-hospital mortality</article-title><source>Rev Bras Cir Cardiovasc</source><year>2012</year><volume>27</volume><issue>1</issue><fpage>66</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">22729303</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rigg</surname><given-names>L</given-names></name><name><surname>Searles</surname><given-names>B</given-names></name><name><surname>Darling</surname><given-names>EM</given-names></name></person-group><article-title>A 2013 survey on pressure monitoring in adult cardiopulmonary
bypass circuits: modes and applications</article-title><source>J Extra Corpor Technol</source><year>2014</year><volume>46</volume><issue>4</issue><fpage>287</fpage><lpage>292</lpage><pub-id pub-id-type="pmid">26357797</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname><given-names>NS</given-names></name><name><surname>Buckberg</surname><given-names>GD</given-names></name><name><surname>Cushen</surname><given-names>CK</given-names></name><name><surname>Whitwam</surname><given-names>CR</given-names></name></person-group><article-title>Inaccuracies and variability of indirect pressure measurements
during cardioplegia administration</article-title><source>Ann Thorac Surg</source><year>1994</year><volume>58</volume><issue>4</issue><fpage>1188</fpage><lpage>1191</lpage><pub-id pub-id-type="pmid">7944784</pub-id></element-citation></ref></ref-list></back></article>